7.339
price down icon3.03%   -0.211
 
loading

Biovie Inc Borsa (BIVI) Ultime notizie

pulisher
09:00 AM

Is BioVie Inc. a good long term investmentAccelerated earnings growth - PrintWeekIndia

09:00 AM
pulisher
07:13 AM

What analysts say about BioVie Inc. stockConsistently high returns - Autocar Professional

07:13 AM
pulisher
04:11 AM

Is BioVie Inc. stock overhyped or has real potentialTremendous wealth creation - jammulinksnews.com

04:11 AM
pulisher
Jul 24, 2025

BioVie Presented Data Highlighting that Patients Treated - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

What drives BioVie Inc. stock priceUnprecedented market success - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Biovie shares climb as Alzheimer’s drug shows promising age deceleration effects - MSN

Jul 24, 2025
pulisher
Jul 24, 2025

Biovie stock rises after drug shows age deceleration in Alzheimer’s patients - Investing.com Australia

Jul 24, 2025
pulisher
Jul 24, 2025

BioVie presents data on Bezisterim at WCAG-2025 - TipRanks

Jul 24, 2025
pulisher
Jul 24, 2025

BioVie Inc. Presents Promising Phase 3 Study Results for Bezisterim in Alzheimer’s Disease at WCAG-2025 - Quiver Quantitative

Jul 24, 2025
pulisher
Jul 24, 2025

Breakthrough: New Alzheimer's Drug Bezisterim Reverses Aging Across 10 Biological Markers, Trial Data Reveals - Stock Titan

Jul 24, 2025
pulisher
Jul 23, 2025

BioVie Expands Board Amid Drug Development Momentum - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

BioVie Inc. Stock Analysis and ForecastConsistently exceptional gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

BioVie appoints Amy Chappell, Kameel Farag to board of directors - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

BioVie Inc. Appoints Dr. Amy S. Chappell and Kameel D. Farag to Board of Directors - Quiver Quantitative

Jul 22, 2025
pulisher
Jul 22, 2025

BioVie Appoints Industry Veterans Amy Chappell, MD, FAAN, and Kameel Farag to Board of Directors - GlobeNewswire

Jul 22, 2025
pulisher
Jul 21, 2025

High-Potential Disruptors in Emerging Sectors: A Strategic Analysis of New to The Street's Featured Innovators - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

New to The Street Episode #679 Airs Tonight on Fox Business Network - New Castle News

Jul 21, 2025
pulisher
Jul 20, 2025

What makes BioVie Inc. stock price move sharplyFree Consultation - beatles.ru

Jul 20, 2025
pulisher
Jul 19, 2025

How high can BioVie Inc. stock price go in 2025Free Stock Market Practical Discussion Forums - beatles.ru

Jul 19, 2025
pulisher
Jul 15, 2025

Why BioVie Inc. stock attracts strong analyst attentionFree Real-Time Market Predictions - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How BioVie Inc. stock performs during market volatilityRisk Aware High Growth Picks - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

New to The Street Episode #678 to Air on Bloomberg TV Featuring Game-Changing Innovators in AI, Biotech, Blockchain, and Sustainability - The Des Moines Register

Jul 12, 2025
pulisher
Jul 09, 2025

BioVie Inc. Presents Promising Data on Bezisterim's Effects on Aging and Neurodegeneration at World Aging and Rejuvenation Conference - Nasdaq

Jul 09, 2025
pulisher
Jul 09, 2025

BioVie Announces Data Highlighting Bezisterim’s Potential to Slow or Reverse Biological Aging and Neurodegeneration Featured as a Keynote Talk at the 7th World Aging and Rejuvenation Conference - The Manila Times

Jul 09, 2025
pulisher
Jul 09, 2025

Breakthrough Alzheimer's Drug Shows Unprecedented 4-Year Biological Age Reversal in Phase 3 Trial - Stock Titan

Jul 09, 2025
pulisher
Jul 08, 2025

BioVie (NASDAQ:BIVI) Stock Price Down 15.6% – Should You Sell? - Defense World

Jul 08, 2025
pulisher
Jul 03, 2025

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of BioVie Inc. (BIVI) - ACCESS Newswire

Jul 03, 2025
pulisher
Jul 01, 2025

BioVie To Carry Out 1-for-10 Reverse Stock Split On July 7th, 2025 - 富途牛牛

Jul 01, 2025
$23.29
price down icon 1.74%
$36.50
price up icon 0.00%
$103.56
price down icon 0.03%
$27.38
price down icon 0.69%
$113.86
price down icon 0.68%
biotechnology ONC
$288.37
price down icon 2.39%
Capitalizzazione:     |  Volume (24 ore):